Inhibition of XPO1 impairs cholangiocarcinoma cell proliferation by triggering p53 intranuclear accumulation-Reference-Cited by-同舟云学术

Inhibition of XPO1 impairs cholangiocarcinoma cell proliferation by triggering p53 intranuclear accumulation

Published:2022-10-05 Issue:5 Volume:12 Page:5751-5763
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Zhao Cheng¹²^ORCID,Ma Ben¹²,Yang Zi‐yi¹²,Li Ou¹²,Liu Shi‐lei¹²,Pan Li‐jia¹²^ORCID,Gong Wei¹²,Dong Ping¹²,Shu Yi‐jun¹²

Affiliation:

1. Laboratory of General Surgery and Department of General Surgery Xinhua Hospital affiliated with Shanghai Jiao Tong University School of Medicine Shanghai China

2. Shanghai Key Laboratory of Biliary Tract Disease Research Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5322

Reference26 articles.

1. Dual Inhibition of mTORC1/2 Reduces Migration of Cholangiocarcinoma Cells by Regulation of Matrixmetalloproteinases

2. The miR-34a/WNT7B modulates the sensitivity of cholangiocarcinoma cells to p53-mediated photodynamic therapy toxicity

3. LINC01714 Enhances Gemcitabine Sensitivity by Modulating FOXO3 Phosphorylation in Cholangiocarcinoma

4. Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E

5. Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selinexor targeting XPO1 promotes PEG3 nuclear accumulation and suppresses cholangiocarcinoma progression;Cancer Chemotherapy and Pharmacology;2024-08-05

2. A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1;Cells;2024-04-04

3. NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14;Cancer Letters;2024-04

4. Molecular Profile of Intrahepatic Cholangiocarcinoma;International Journal of Molecular Sciences;2023-12-29

5. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis;World Journal of Surgical Oncology;2023-09-18